You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 557 Determining the efficacy of ADCC by the 3D-EX ex vivo platform utilizing tumoroids of fresh patient tumor samples with intact tumor microenvironment

Alerts

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Immune-stimulants and immune modulators
557 Determining the efficacy of ADCC by the 3D-EX ex vivo platform utilizing tumoroids of fresh patient tumor samples with intact tumor microenvironment
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address